TheProfitWatch

SILO - Silo Pharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.36 0.03 (8.1%) --- -0.01 (-1.54%) 0.01 (2.14%) 0.0 (-0.08%) 0.02 (6.28%) 0.0 (-0.03%) -0.01 (-1.76%)

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.23
Diluted EPS:
-0.23
Basic P/E:
-1.7098
Diluted P/E:
-1.7098
RSI(14) 1m:
50.59
VWAP:
0.39
RVol:

Events

Period Kind Movement Occurred At

Related News